Cargando…
The Effects of Sickle Cell Disease on the Quality of Life: A Focus on the Untold Experiences of Parents in Tanzania
Tanzania is among the top five countries with a high burden of sickle cell disease (SCD) in the world. Even though the effects of SCD on quality of life have been documented in other countries including Nigeria and the United States of America, few are known from Tanzania. Therefore, this study focu...
Autores principales: | Kilonzi, Manase, Mwakawanga, Dorkasi L., Felician, Fatuma Felix, Mlyuka, Hamu J., Chirande, Lulu, Myemba, David T., Sambayi, Godfrey, Mutagonda, Ritah F., Mikomangwa, Wigilya P., Ndunguru, Joyce, Jonathan, Agnes, Ruggajo, Paschal, Minja, Irene Kida, Balandya, Emmanuel, Makani, Julie, Sirili, Nathanael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180017/ https://www.ncbi.nlm.nih.gov/pubmed/35682454 http://dx.doi.org/10.3390/ijerph19116871 |
Ejemplares similares
-
Barriers and Facilitators of Availability of Hydroxyurea for Sickle Cell Disease in Tanzania; A Qualitative Study of Pharmaceutical Manufacturers, Importers, and Regulators
por: Mlyuka, Hamu J., et al.
Publicado: (2022) -
Nasopharyngeal Carriage and Antibiogram of Pneumococcal and Other Bacterial Pathogens from Children with Sickle Cell Disease in Tanzania
por: Mutagonda, Ritah F, et al.
Publicado: (2022) -
Level of knowledge among health care providers on preparation of injectable artesunate for treatment of severe malaria in public health facilities in Tanzania
por: Mikomangwa, Wigilya P., et al.
Publicado: (2019) -
Promoting access of hydroxyurea to sickle cell disease individuals: Time to make it an essential medicine
por: Kilonzi, Manase, et al.
Publicado: (2022) -
Level of medication self-management capacity among patients on ambulatory care exiting hospital pharmacy at Muhimbili National Hospital, Tanzania: a descriptive cross-sectional study
por: Mlyuka, Hamu, et al.
Publicado: (2019)